Nature Communications, 2017 · DOI: 10.1038/s41467-017-00583-8 · Published: August 1, 2017
Following spinal cord injuries, fluid-filled cysts can form, hindering tissue repair. This study introduces an injectable hydrogel, I-5, designed to address this issue by eliminating cystic cavities. The hydrogel works by promoting the formation of a fibronectin-rich extracellular matrix (ECM) that bridges the cavities. This remodeling is facilitated by macrophages, which express matrix metalloproteinase-9 (MMP-9). The I-5 hydrogel also improves coordinated movement and protects nerve fibers. This suggests the hydrogel's ability to interact with inflammatory cells and promote ECM remodeling can aid tissue repair after CNS injuries.
Injectable biomaterials can be designed to interact with inflammatory cells, promoting beneficial ECM remodeling and tissue repair after CNS injuries.
The injectable hydrogel can potentially be used as a clinically applicable bridging strategy to eliminate cystic cavities after spinal cord injuries.
I-5 can act as a carrier for therapeutic reagents such as drugs (Taxol) and nucleotides (siRNA) for targeted delivery to the injury site.